Journal of Neuroscience, Vol 13, 2601-2609, Copyright © 1993 by Society for Neuroscience
Interleukin-1 induces substance P in sympathetic ganglia through the induction of leukemia inhibitory factor (LIF)
AM Shadiack, RP Hart, CD Carlson and GM Jonakait
Department of Biological Sciences, Rutgers University, Newark, New Jersey 07102.
It has become increasingly clear that immune cytokines perform growth and
differentiation functions in the nervous system similar to those performed
in the immune system. In previous studies we have shown that interleukin-1
beta (IL-1 beta) raises substance P (SP) and the mRNA coding for its
preprotachykinin precursor in cultured sympathetic superior cervical
ganglia (SCG) (Jonakait and Schotland, 1990; Hart et al., 1991a). The
action of IL-1 is blocked both by depolarization of the ganglia and by
glucocorticoid hormones (Hart et al., 1991a). In the present report, we
have found that IL-1 does not act directly upon neurons to raise SP, but
rather induces the production of a soluble intermediate molecule that
raises both SP and the cholinergic-specific enzyme ChAT. Its induction by
IL-1 is blocked by the synthetic glucocorticoid hormone dexamethasone; its
action is compromised under depolarizing conditions. Because medium
conditioned by IL-1 (IL-1CM) is functionally similar to leukemia inhibitory
factor (LIF), we sought to determine whether this molecule might be an
active constituent of IL- 1CM. Immunoprecipitation with an antiserum
directed against LIF eliminated large proportions of SP-inducing activity
from IL-1CM. In addition, steady-state levels of mRNA coding for LIF are
increased by IL-1 treatment of SCG. These data suggest that LIF, induced by
IL-1, may ultimately be responsible for the IL-1 induction of SP.